A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.
Managers at Investment Week's June Funds to Watch conference share their views on what to expect from the rest of 2017 and beyond.
Chinese labour no longer as cheap as elsewhere
'Sell in May and come back on St. Leger’s Day'
'Final blow' to Obama's legacy
Volatility hits 23-year lows